Market news alert: dariohealth beats q4 expectations, reports 398% growth in b2b recurring revenue

New york--(business wire)---- $drio #biotech--market news alerts updates: market news alerts reports: dariohealth corp. (nasdaq: drio) reported fourth quarter revenue of $7.6 million, beating analyst consensus of $7.39 million. b2b2c recurring revenue surged 398% year-over-year to $5.6 million in q4, driven by rapid employer and health plan adoption of the company's comprehensive chronic care platform. gross margins in the b2b2c business exceeded 80% over the past three quarters. full-year 2024 revenue reached $2.
DRIO Ratings Summary
DRIO Quant Ranking